ConductScience.org, home

Library / Trials

Negative Pressure Wound Therapy Versus Direct Skin Closure for Burst Abdomen

NCT07922629, Not applicable, Completed, Alexandria University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleNegative Pressure Wound Therapy Versus Direct Skin Closure for Burst AbdomenClinicalTrials.gov
NCT numberNCT07922629ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment45 participants, actualClinicalTrials.gov
Lead sponsorAlexandria UniversityClinicalTrials.gov
ConditionsBurst Abdomen, Surgical Wound Dehiscence, Abdominal Wound DehiscenceClinicalTrials.gov
InterventionsNegative Pressure Wound Therapy, Direct Skin ClosureClinicalTrials.gov
First posted2026-11-06ClinicalTrials.gov
Last updated2026-11-06ClinicalTrials.gov

Registered outcomes 12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryDefinitive Aponeurotic (Fascial) ClosureUp to 3 months after the index procedureProportion of participants in whom complete closure of the abdominal wall fascia (aponeurosis) was achieved, assessed clinically.ClinicalTrials.gov
SecondaryIntra-Abdominal PressureAt the first, second and third postoperative measurement sessions (within the first week after the index procedure)Intra-abdominal pressure in mmHg, measured indirectly as urinary bladder pressure through a Foley catheter connected to a saline-filled monitoring system.ClinicalTrials.gov
SecondaryNumber of Sessions to Definitive Closureup to 3 monthsNumber of dressing or operative sessions required until definitive fascial closure.ClinicalTrials.gov
SecondaryTime to Definitive ClosureUp to 3 monthsTime in days from the index procedure to definitive fascial closureClinicalTrials.gov
SecondaryLength of Hospital StayFrom the index procedure until discharge, up to 3 monthNumber of days from the index procedure to hospital dischargeClinicalTrials.gov
SecondarySurgical Site InfectionUp to 3 monthsProportion of participants with surgical site infection, diagnosed clinically.ClinicalTrials.gov
SecondaryEnteroatmospheric or Enterocutaneous FistulUp to 3 monthsProportion of participants who develop an enteroatmospheric or enterocutaneous fistula.ClinicalTrials.gov
SecondaryUnplanned ReoperationUp to 3 monthsProportion of participants requiring an unplanned return to the operating room for a complication.ClinicalTrials.gov
SecondaryAbdominal Compartment SyndromeFrom the index procedure until discharge, up to 3 monthsProportion of participants who develop abdominal compartment syndrome, defined as sustained intra-abdominal pressure above 20 mmHg with new organ dysfunction.ClinicalTrials.gov
SecondaryIntraoperative ComplicationsDuring the index procedureProportion of participants with intraoperative complications such as bleeding or visceral injury during the index procedure.ClinicalTrials.gov
SecondaryReadmissionUp to 3 monthsProportion of participants readmitted to hospital after discharge.ClinicalTrials.gov
SecondaryAll-Cause MortalityUp to 3 monthsProportion of participants who die from any cause.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)